Call Help Lines
954-785-1121

>>> UPGRADE YOUR MEMBERSHIP NOW AND GET IT ALL - CLICK HERE
CANSLIM.net Stock Bulletin - Viasys Healthcare Inc (VAS)
Monday, January 30, 2006   CANSLIM.net
 

Viasys Healthcare Inc.

 

Ticker Symbol: VAS (NYSE)

Industry Group: Medical Equipment Wholesale

Shares Outstanding:  31,670,000

Price: $28.75 Jan 27

Day's Volume: 453,100 1/28/2006 Jan 27

Shares in Float:  31,110,000

52 Week High: $29.21 1/28/2006 Jan 27

50-Day Average Volume: 238,800

Up/Down Volume Ratio: 1.2

Pivot Point: $28.89 (12/05/05 high plus $0.10)

Pivot Point +5% = Max Buy Price: $30.33

Web Address: www.viasyshealthcare.com/

C A N S L I M | StockTalk | News | Chart | SEC | Zacks Reports

Viasys Healthcare, Inc. (VAS) is a global market leader in health-care technology--a distinction that is built on a solid history of innovation, superior product performance, and a commitment to customer service. VIASYS Healthcare comprises many well-established companies that are each recognized for market leadership. These companies specialize in developing, manufacturing, marketing, and servicing high-technology medical devices that are used in respiratory care, neurology, vascular medicine, critical care, and the medical and surgical product markets. Their products are used to assist physicians in the diagnosis and treatment of cardiopulmonary, digestive, neurological, respiratory, and vascular disorders for neonatal, pediatric, and adult patients. Its customers include hospitals, alternate care sites, clinical laboratories, and private physicians in over 100 countries.  A steady acquisition program (5 during the past year), coupled with strong organic growth, has resulted in an acceleration of earnings and sales growth.  Sales have grown from 7% to 32% to 39% during the past three quarterly reports (Mar, Jun, Sept '05), while earnings per share have risen from 33% to 62% to 186% during the same timeframe versus the year earlier period.  For fiscal year 2005, Wall Street is forecasting earnings per share to jump 63% to $0.96 and another 32% to $1.27 for fiscal year 2006.  VAS is a member of the 15th ranked Medical-Systems/Equipment sector for relative price performance out of 197 industry groups, and capital has been flowing into the group as its performance has improved from a ranking of 24th three months ago.

What to Look For and What to Look Out For:  A move above the $28.89 mark on at least +50% above average volume would trigger a proper technical buy signal.  Long tails in the candlestick chart suggest that it has encountered ample selling pressure at the $28.79 area in the past.  This evidence of previous resistance, coupled with the stock’s inability to hold above that level during the January 27th session, serve as a reminder that investors should avoid buying in anticipation of the breakout and wait for a legitimate showing of institutional buying demand first.  In addition, while the stock’s Relative Strength rating of 82 meets the minimum requirement, the fact that the RS line has not yet broken out to new highs to confirm the stock's advance raises a cautionary flag.  Also, a more bullish up/down volume ratio of greater than the stock’s present 1.2 would be more comforting as well. Any deterioration under the 50 DMA line would prompt concern, especially if volume were to swell above average.

Technical Analysis:  On November 4th, solid third quarter earnings results and equally bullish guidance served as a catalyst for VAS’ stock to rise above virtually all resistance.  On that day it vaulted +7.7% to $26.70 as volume swelled to 1.4 million shares traded, which was several times its average daily volume.  Subsequently, the stock rallied to the $28.79 level before pulling back in early January to successfully test support near the November 1st gap up.  The uptrend has since resumed, with the stock currently poised near all-time highs.


About : Frank E. Testa
Frank E. Testa has earned his Chartered Market Technician (CMT) designation and is a Director & Chief Technical Analyst at Ipreo. Frank is a devoted practitioner of the CAN SLIM® methodology and a regular contributor to CANSLIM.net. In addition, Frank is the author of "Candlesticks: Shedding the Light on Pattern Analysis" and developer of the Power Point and Figure Charting Method that was published in "The Journal of Technical Analysis." Frank can be reached at Frank.Testa@ipreo.com.
You can contact Frank E. Testa at frank.testa@cap-bridge.com

 
The information and writings made avaialable by individuals that successfully passed the  CAN SLIM® Masters Program are their own.  Copyright © 1996-2024 Gruneisen Growth Corp. All rights reserved. Protected by the copyright laws of the United States and Canada and by international treaties. 


Kenneth J. Gruneisen founded Gruneisen Growth Corp. (2003), which prior to May 11, 2015, operated CANSLIM.net and CANSLIM.com both under license from Data Analysis Inc. / Investor's Business Daily. Kenneth has passed the CAN SLIM® Master's Exam. Gruneisen Growth Corp. now continues over two decades of fact based market analysis via FactBasedInvesting.com.

Copyright © 1996-2024 Gruneisen Growth Corp. All rights reserved. Protected by the copyright laws of the United States and Canada and by international treaties

Privacy Policy | Terms of Use | Contact Us